Source:http://linkedlifedata.com/resource/pubmed/id/19850936
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
51
|
pubmed:dateCreated |
2009-12-16
|
pubmed:abstractText |
Cellular prion protein (PrP(c)) undergoes a disintegrin-mediated physiological cleavage, generating a soluble amino-terminal fragment (N1), the function of which remained unknown. Recombinant N1 inhibits staurosporine-induced caspase-3 activation by modulating p53 transcription and activity, whereas the PrP(c)-derived pathological fragment (N2) remains biologically inert. Furthermore, N1 protects retinal ganglion cells from hypoxia-induced apoptosis, reduces the number of terminal deoxynucleotidyltransferase-mediated biotinylated UTP nick end labeling-positive and p53-immunoreactive neurons in a pressure-induced ischemia model of the rat retina and triggers a partial recovery of b-waves but not a-waves of rat electroretinograms. Our work is the first demonstration that the alpha-secretase-derived PrP(c) fragment N1, but not N2, displays in vivo and in vitro neuroprotective function by modulating p53 pathway. It further demonstrates that distinct N-terminal cleavage products of PrP(c) harbor different biological activities underlying the various phenotypes linking PrP(c) to cell survival.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Casp3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/PrPC Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Staurosporine,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
18
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35973-86
|
pubmed:dateRevised |
2010-12-21
|
pubmed:meshHeading |
pubmed-meshheading:19850936-Animals,
pubmed-meshheading:19850936-Apoptosis,
pubmed-meshheading:19850936-Caspase 3,
pubmed-meshheading:19850936-Cell Hypoxia,
pubmed-meshheading:19850936-Cell Survival,
pubmed-meshheading:19850936-Cells, Cultured,
pubmed-meshheading:19850936-Disease Models, Animal,
pubmed-meshheading:19850936-Enzyme Inhibitors,
pubmed-meshheading:19850936-Humans,
pubmed-meshheading:19850936-Mice,
pubmed-meshheading:19850936-PrPC Proteins,
pubmed-meshheading:19850936-Rats,
pubmed-meshheading:19850936-Recombinant Proteins,
pubmed-meshheading:19850936-Retinal Ganglion Cells,
pubmed-meshheading:19850936-Staurosporine,
pubmed-meshheading:19850936-Transcription, Genetic,
pubmed-meshheading:19850936-Tumor Suppressor Protein p53
|
pubmed:year |
2009
|
pubmed:articleTitle |
The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.
|
pubmed:affiliation |
Institut de Pharmacologie Moléculaire et Cellulaire and Institut de Neuromédecine Moléculaire, UMR6097 CNRS/UNSA, Equipe Labellisée Fondation pour la Recherche Médicale, 660 Route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|